Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Endometriosis Related Pain Clinical Trial
SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigator Site - Winston Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Endometriosis Related Pain Clinical Trial
SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Status: Enrolling, Phase III
Updated: 12/31/1969
Aventura
mi
from
Aventura, FL
Click here to add this to my saved trials
Endometriosis Related Pain Clinical Trial
SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Status: Enrolling, Phase III
Updated: 12/31/1969
Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Endometriosis Related Pain Clinical Trial
SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Status: Enrolling, Phase III
Updated: 12/31/1969
Lafayette
mi
from
Lafayette, IN
Click here to add this to my saved trials
Endometriosis Related Pain Clinical Trial
SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Status: Enrolling, Phase III
Updated: 12/31/1969
Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Endometriosis Related Pain Clinical Trial
SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Status: Enrolling, Phase III
Updated: 12/31/1969
Sandy Springs
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Endometriosis Related Pain Clinical Trial
SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Beach
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastrointestinal Diseases Research
mi
from
Columbus, GA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Midwest Biomedical Research Foundation - NAVREF
mi
from
Kansas City, MO
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trials of SWLA, LLC
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Health Center at UWMC
mi
from
Seattle, WA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Northside Gastroenterology
mi
from
Cypress, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Exemplar Research
mi
from
Elkins, WV
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mid Atlantic Health Specialists
mi
from
Galax, VA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tibor Rubin VA Medical Center - NAVREF
mi
from
Long Beach, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
United Medical Doctors
mi
from
Murrieta, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Dupage Medical Group
mi
from
Oakbrook Terrace, IL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Care Access Research, San Pablo
mi
from
San Pablo, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
CHI Franciscan Digestive Care Associates
mi
from
Tacoma, WA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Gastroenterology-Union City
mi
from
Union City, TN
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Inquest Clinical Research/Coastal Gastroenterology Associates, PA
mi
from
Webster, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
UMASS Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Disease Associates - Interspond - PPDS
mi
from
Wyomissing, PA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Summit Clinical Research, LLC
mi
from
Athens, GA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley View Wellness and Medical Center - VVCRD Clinical Research
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Associates
mi
from
Greenville, SC
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research of South Nevada - CROSN
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Upland Clinical Research
mi
from
Upland, CA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Cardinal Internal Medicine
mi
from
Woodbridge, VA
Click here to add this to my saved trials
Musculoskeletal Clinical Trial
Inpatient Multimodal Path to RecOVEry
Status: Enrolling
Updated: 10/2/2017
Carolinas Healthcare System - Stanly
mi
from
Albemarle, NC
Click here to add this to my saved trials
Musculoskeletal Clinical Trial
Inpatient Multimodal Path to RecOVEry
Status: Enrolling
Updated: 10/2/2017
Carolinas Healthcare System - Lincoln
mi
from
Lincolnton, NC
Click here to add this to my saved trials
Musculoskeletal Clinical Trial
Inpatient Multimodal Path to RecOVEry
Status: Enrolling
Updated: 10/2/2017
Carolinas Healthcare System - Anson
mi
from
Wadesboro, NC
Click here to add this to my saved trials
Healthy Subject Clinical Trial
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Ohio State University, Stefanie Spielman Comprehensive Breast Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in Her-positive, Her2-positive Metastatic Breast
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Perlmutter Cancer Center NYU Langone
mi
from
New York, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Alcohol Research Consortium in HIV-Intervention Research Arm
Status: Enrolling, Phase IV
Updated: 12/31/1969
Harborview Medical Center; 2 West Clinic; UW Center for AIDS
mi
from
Seattle, WA
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Phase 1 Evaluation of [18F]MK-6240 PET as an Imaging Marker for Tau Protein
Status: Enrolling, Phase
Updated: 12/31/1969
Invicro
mi
from
New Haven, CT
Click here to add this to my saved trials
Metastatic Pancreatic Cancer Clinical Trial
RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Rexahn Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Metastatic Pancreatic Cancer Clinical Trial
RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Rexahn Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Eosinophilic Esophagitis (EoE) Clinical Trial
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Pediatric Gastroenterology
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical Center of Baton Rouge
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center at West County Hospital
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Broadway Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Chronic Insomnia Clinical Trial
Mobile Intervention to Improve Functional Health and Community Engagement of Post-9/11 Veterans With Chronic Insomnia
Status: Enrolling
Updated: 3/19/2018
Edith Nourse Rogers Memorial VA Hospital
mi
from
Bedford, MA
Click here to add this to my saved trials
Nephrology / Urology, Other Clinical Trial
Prospective Research Rare Kidney Stones (ProRKS)
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Hospital, Harvard Medical School
mi
from
Boston, MA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Treatment of Depression With Connectivity Guided Robotically Delivered rTMS
Status: Enrolling
Updated: 10/9/2017
Ikare, Mood, Trauma, Recovery Clinic
mi
from
San Antonio, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
JBT-101 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology
mi
from
La Jolla, CA
Click here to add this to my saved trials
EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer Clinical Trial
A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer Clinical Trial
A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Evanston, IL
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Michigan Health System; UMH Internal Medicine/Hematology-Oncology
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Roswell Park Cancer Institute; Grace Cancer Drug Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Tennessee Oncology - Chattanooga; Tennessee Oncology - East Third Street
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Ohio State University; B406 Starling-Loving Hall
mi
from
Columbus, OH
Click here to add this to my saved trials
Spinal Deformity Clinical Trial
Prospective, Multi-Center Adult Spinal Deformity Outcomes Database Registry
Status: Enrolling
Updated: 10/10/2017
Baylor Scoliosis Center
mi
from
Plano, TX
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Palm Coast, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Abington, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Annapolis, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigational Site Number 8400001
mi
from
Bridgeton, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Burlington, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Crystal River, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Endwell, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Eunice, LA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fleming Island, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fountain Hills, AZ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hampton, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Indian Land, SC
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Lipid Research Clinic, University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kalispell, MT
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
La Crosse, WI
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Linden, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Natrona Heights, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Northridge, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Odessa, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pell City, AL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rock Island, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rockford, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saginaw, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Victoria, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
York, PA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety and Efficacy of MEDI0457 and Durvalumab in Patients With HPV Associated Recurrent/Metastatic Head and Neck Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety and Efficacy of MEDI0457 and Durvalumab in Patients With HPV Associated Recurrent/Metastatic Head and Neck Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety and Efficacy of MEDI0457 and Durvalumab in Patients With HPV Associated Recurrent/Metastatic Head and Neck Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety and Efficacy of MEDI0457 and Durvalumab in Patients With HPV Associated Recurrent/Metastatic Head and Neck Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety and Efficacy of MEDI0457 and Durvalumab in Patients With HPV Associated Recurrent/Metastatic Head and Neck Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety and Efficacy of MEDI0457 and Durvalumab in Patients With HPV Associated Recurrent/Metastatic Head and Neck Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety and Efficacy of MEDI0457 and Durvalumab in Patients With HPV Associated Recurrent/Metastatic Head and Neck Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials